Clinical TrialsSearch results
Number of results: 805
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Evaluation of the efficacy of Tiotropium/Olodaterol by a dynamic flat-panel detector system
- Chronic Obstructive Pulmonary Disease
- Ikari Jun
- 2022-01-11
Recruiting
- Development of Diagnostic Imaging of Malignant Tumor using New PET Probe AIB
- Malignant neoplasms
- Tamura Kentaro
- 2022-01-06
Recruiting
- Addition of binimetinib after refractory to encorafenib and cetuximab in patients with BRAF V600E-mutatnt metastatic colorectal cancer
- Unresectable, advanced or recurrent colorectal cancer with BRAF V600E mutation
- Bando Hideaki
- 2022-01-01
Recruiting
- Triplet rechallenge of BEACON regimen for RAS wild-type and BRAF V600E mutant metastatic colorectal cancer
- Unresectable, advanced or recurrent colorectal cancer with RAS wild-type and BRAF V600E mutation
- Kotani Daisuke
- 2022-01-01
Recruiting
- the effect of high-resolution natural sound for healing, anxiety and other sympotms among advanced cancer patients ~ pilot study ~
- cancer
- Miura Tomofumi
- 2021-12-27
Recruiting
- Pilot study of New Generation Arrhythmia Treatment
- atrial fibrillation
- Wakatsuki Masaru
- 2021-12-22
Not yet recruiting
- Phase 1 Study of NIB101 in Participants with Advanced Solid Tumors
- Solid tumor
- Tanaka Michihiko
- 2021-12-18
Recruiting
- Development of Diagnostic Imaging of Pancreatic Cancer using New PET Probe MePro
- pancreatic cancer
- Yamazaki Kana
- 2021-12-07
Not yet recruiting
- A Phase 1/2 Open-Label, Multicenter Study of INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders
- Anemia, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis
- Ueda Eiji
- 2021-11-24
Recruiting
- The relationship of the pharmacokinetic parameters of ganciclovir with the efficacy and the patient safety
- Cytomegalovirus infection and disease
- Sakaida Emiko
- 2021-11-02